Corebridge Financial’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,849
| Closed | -$438K | – | 1829 |
|
|
2025
Q1 | $438K | Buy |
36,849
+1,942
| +6% | +$23.1K | ﹤0.01% | 1670 |
|
|
2024
Q4 | $658K | Buy |
34,907
+770
| +2% | +$14.5K | ﹤0.01% | 1534 |
|
|
2024
Q3 | $767K | Buy |
34,137
+1,580
| +5% | +$35.5K | ﹤0.01% | 1499 |
|
|
2024
Q2 | $679K | Buy |
+32,557
| New | +$679K | ﹤0.01% | 1539 |
|